Why the study?
Despite increasing telehealth utilization in cardiovascular disease management, factors such as technological infrastructure, reimbursement, and limited patient digital literacy hinder adoption.
This AHA scientific statement outlines the role, benefits, and barriers of telehealth in managing cardiovascular and peripheral vascular diseases.
Supports telehealth integration in cardiovascular care despite barriers; extends AHA guidance and prioritizes research on equitable adoption.
Telehealth enables the remote delivery of health care through telecommunication technologies and has substantially affected the evolving medical landscape. The COVID-19 pandemic accelerated the utilization of telehealth as health care professionals were forced to limit face-to-face in-person visits. It has been shown that information delivery, diagnosis, disease monitoring, and follow-up care can be conducted remotely, resulting in considerable changes specific to cardiovascular disease management. Despite increasing telehealth utilization, several factors such as technological infrastructure, reimbursement, and limited patient digital literacy can hinder the adoption of remote care. This scientific statement reviews definitions pertinent to telehealth discussions, summarizes the effect of telehealth utilization on cardiovascular and peripheral vascular disease care, and identifies obstacles to the adoption of telehealth that need to be addressed to improve health care accessibility and equity.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: